VERU INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
VERU INC. (VERU) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $7.28 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2013-08-01
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $7.28M, a 15.89% decline year-over-year.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $9.48M, a 21.34% increase year-over-year.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $9.91M, a 14.79% increase year-over-year.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $9.91M, a 39.53% increase year-over-year.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $35.01M, a 89.09% increase from fiscal 2011.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2011 was $18.52M, a 16.55% decline from fiscal 2010.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2010 was $22.19M, a 18.97% decline from fiscal 2009.
- VERU INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2009 was $27.38M.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $7.28M 10-Q · filed 2013-08-01 | $16.76M derived: sum of 2 quarters · filed 2013-08-01 | $26.67M 10-Q · filed 2013-08-01 | $36.58M derived: sum of 4 quarters · filed 2013-08-01 |
| 2013-03-31 | $9.48M 10-Q · filed 2013-05-02 | $19.39M 10-Q · filed 2013-05-02 | $29.30M derived: sum of 3 quarters · filed 2013-05-02 | $37.96M derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-12-31 | $9.91M 10-Q · filed 2013-01-30 | $19.82M derived: sum of 2 quarters · filed 2013-01-30 | $28.48M derived: sum of 3 quarters · filed 2013-08-01 | $36.29M derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-09-30 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $18.57M derived: sum of 2 quarters · filed 2013-08-01 | $26.38M derived: sum of 3 quarters · filed 2013-08-01 | $35.01M 10-K · filed 2012-12-04 |
| 2012-06-30 | $8.66M 10-Q · filed 2013-08-01 | $16.47M derived: sum of 2 quarters · filed 2013-08-01 | $25.10M 10-Q · filed 2013-08-01 | $32.20M derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-03-31 | $7.81M 10-Q · filed 2013-05-02 | $16.44M 10-Q · filed 2013-05-02 | $23.55M derived: sum of 3 quarters · filed 2013-05-02 | $27.06M derived: sum of 4 quarters · filed 2013-05-02 |
| 2011-12-31 | $8.63M 10-Q · filed 2013-01-30 | $15.74M derived: sum of 2 quarters · filed 2013-01-30 | $19.25M derived: sum of 3 quarters · filed 2013-01-30 | $23.51M derived: sum of 4 quarters · filed 2013-01-30 |
| 2011-09-30 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $10.62M derived: sum of 2 quarters · filed 2012-12-04 | $14.88M derived: sum of 3 quarters · filed 2012-12-04 | $18.52M 10-K · filed 2012-12-04 |
| 2011-06-30 | $3.52M 10-Q · filed 2012-07-31 | $7.77M derived: sum of 2 quarters · filed 2012-07-31 | $11.41M 10-Q · filed 2012-07-31 | $19.19M derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $4.26M 10-Q · filed 2012-05-01 | $7.90M 10-Q · filed 2012-05-01 | $15.67M derived: sum of 3 quarters · filed 2012-12-04 | $17.42M derived: sum of 4 quarters · filed 2012-12-04 |
| 2010-12-31 | $3.64M 10-Q · filed 2012-01-31 | $11.42M derived: sum of 2 quarters · filed 2012-12-04 | $13.16M derived: sum of 3 quarters · filed 2012-12-04 | |
| 2010-09-30 | $7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $9.52M derived: sum of 2 quarters · filed 2012-12-04 | $22.19M 10-K · filed 2012-12-04 | |
| 2010-06-30 | $1.74M 10-Q · filed 2011-08-05 | $14.41M 10-Q · filed 2011-08-05 | ||
| 2009-09-30 | $27.38M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |